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Uterine leiomyosarcoma (LMS) is a rare tumor constituting 1% of all uterinemalignancies.This sarcoma demonstrates an aggressive
growth pattern with an high rate of recurrence with hematologic dissemination; the most common sites are lung, liver, and
peritoneal cavity, head and neck district being rarely interested. Only other four cases of metastasis in the oral cavity have been
previously described. The treatment of choice is surgery and the use of adjuvant chemotherapy and radiation has limited impact
on clinical outcome. In case of metastases, surgical excision can be performed considering extent of disease, number and type of
distant lesions, disease free interval from the initial diagnosis to the time of metastases, and expected life span. We illustrate a case
of uterine LMSmetastasis in the upper buccal gingiva that occurred during chemotherapy in a 63-year-old woman that underwent
a total abdominal hysterectomy with bilateral salpingo-oophorectomy for a diagnosis of LMS staged as pT2bN0 and that developed
lung metastases eight months after primary treatment. Surgical excision of the oral mass (previously misdiagnosed as epulis at a
dental center) and contemporary reconstruction with pedicled temporalis muscle flap was performed in order to improve quality
of life. Even if resection was achieved in free margins, “local” relapse was observed 5 months after surgery.
1. Introduction
Uterine leiomyosarcomas (LMSs) constitute 1% of all uterine
malignancies and approximately 25% of uterine sarcomas,
that are rare tumors that account for only 3% to 7% of
all uterine cancers [1, 2]. They demonstrate an aggressive
growth pattern with a high rate of recurrence with hemato-
logic dissemination; the most common sites are lung, liver,
and peritoneal cavity [3]. Head and neck district is rarely
interested, and only other four cases of metastasis in the oral
cavity have been previously described [4]. In particular, we
illustrate the second case of metastasis in the upper buccal
gingiva in a 63-year-old woman in which lungmetastasis was
also present.
2. Case Report
A 63-year-old woman with a history of advanced uterine
LMS presented to our center with a painful, ulcerated
swelling on the right upper buccal gingiva (Figure 1). She
underwent a total abdominal hysterectomy with bilateral
salpingo-oophorectomy for a diagnosis of LMS staged as
pT2bN0 fourteen months previously. Eight months after
primary treatment she developed two bilateral lung masses
(SUV max: 7.8 at (18)F-fluoride PET/CT); histological exam-
ination of the 11mm lung mass in the right chest revealed a
metastasis of LMS. An adjunctive lung mass was present in
the left chest. Chemotherapy was administered, initially with
isofosfamide-epidoxorubicin, with scarce tolerance (grade
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Figure 1: Preoperative intraoral view of the lesion.
Figure 2: Preoperative axial CT scans with contrast showing left
upper alveolar crest lesion.
3-4 neuthropenia) so that it was decided to administer
taxotere. During this treatment she developed a rapidly
growing mass in the right upper buccal gingiva. She was
referred to her dentistry that performed an excisional biopsy
under local anesthesia suspecting a “haemorragic epulis.”
Histological examination was compatible with metastasis of
leiomyosarcoma, incompletely excised. ACT scan performed
about 1 month after resection revealed an osteolytic lesion of
30 × 35mm of the upper maxilla (Figure 2); MRI was not
performed because the patient was claustrophobic. Because
of the rapid growth observed just in 40 days, it was decided
according to oncologist to perform a partial maxillectomy
and contemporary reconstruction with temporalis muscle
pedicled flap even if a lung metastasis was present. His-
tological examination confirmed the presence of a 6 cm
spindle cells LMS, entirely excised. Immunohistochemical
analysis against monoclonal antibodies for a-smooth muscle
actin (a-SMA), desmin, HHF-35, caldesmon, and vimentin
was positive; mitotic index (Ki67) was of 90% (Figure 3).
Considering the radical excision, no “adjuvant” radiotherapy
on the oral cavity was administered. In order to control
lung metastasis and considering the aggressiveness of the
disease, it was decided to perform two other cycles of
chemotherapy with ifofosfamide-epidoxorubicin. A partial
regression of the lung metastasis was obtained, but again it
was impossible to continue treatment because of high toxicity.
A PET-CT performed 3 months after surgery revealed a right
femur metastasis, so that radiotherapy was performed. Two
months later, after an episode of epistaxis, head and neck
CT scan with contrast revealed a relapse in the masticatory
space and rinopharynx: the patient was referred to palliative
radiotherapy.
3. Discussion
LMSs usually arise in anatomical sites with abundant smooth
muscle, such as gastrointestinal tract, retroperitoneum, and
uterus; nevertheless, uterine LMSs constitute only 1% of
all uterine malignancies [1, 2, 4]. Despite variable results,
patients with uterine LMS have an overall poor prognosis
with a long-term 5-year survival and risk of recurrence
ranging from 25% to 75%, even if these tumors are usually
confined to the uterus at the time of diagnosis [5, 6]. The
majority of patients who recur do so within 2 years of initial
diagnosis, and up to 90% of patients who fail show distant
metastases either alone or concurrent with pelvic recurrence.
In our case, the tumor was confined to the uterus at the time
of diagnosis, and distant metastases to the lung were detected
eight months after primary treatment. The most common
sites of recurrence are peritoneal cavity (30–50% of cases),
lung (30–40%), and liver (about 10%); only rarely do they
involve the brain and skull (<1%) owing to pulmonary arterial
circulation [7]. Metastatic uterine LMS to the oral cavity are
extremely rare, and only four other cases have been previously
described [4, 8]. Also considering LMSs originated from
other primary sites, only other three cases with metastasis to
oral cavity can be found [8, 9]. The rarity of buccal mucosa
involvement can be due to the fact that in the oral cavity
smooth muscle is very scarce, being present in the blood
vessel walls and the circumvallate papillae of the tongue. Kim
et al. hypothesize that “the metastatic mass must be related
to the blood vessels in the buccal cheek, and the maxillary
gingivae with haematogenous spread from the uterus via lung
to the oral cavity” [4]. In our case oral metastasis to the upper
gingival developed after lungmetastases.They also found that
metastatic tissue was different from tissue from primary site,
beingmore vascularized and composed by cellsmore spindle-
shaped moderately positive to the a-SMA antibody [4]. In
our case it was impossible to compare the two specimens,
because the patient underwent total abdominal hysterectomy
with bilateral salpingo-oophorectomy at another center. The
treatment of choice of uterine LMS is surgery and the
use of adjuvant treatment has limited impact on clinical
outcome, and radiotherapy seems only to improve local
control, because most recurrences develop at distant sites
[6, 10]. The most common chemotherapic agent used for
LMSs is doxorubicin, usually associated with ifofosfamide
[10, 11]. In this case no adjuvant radiotherapy was admin-
istered after total abdominal hysterectomy with bilateral
salpingo-oophorectomy, and chemotherapy was started after
the detection of lungmetastases. In case ofmetastatic disease,
factors that would contribute to the decision of operability
would include extent of tumor (TNM), number and type of
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Figure 3: (a) Hematoxylin eosin stain of the specimen (2x HPF). (b) Hematoxylin eosin stain of the specimen (10x HPF). (c) Immunohis-
tochemistry showing positivity to a-smooth muscle actin (a-SMA) (2x HPF). (d) Immunohistochemistry showing positivity to a-smooth
muscle actin (a-SMA) (10x HPF). ((e) and (f)) Immunohistochemistry revealing a mitotic index (Ki-67) of 90% positivity (2x HPF and 10x
HPF).
metastases, disease free interval from the initial diagnosis
to the time of metastases, and expected life span [7]. In
our case, the decision to proceed with surgical removal
of the upper gingiva mass, even in presence of advanced
disease, was taken in order to improve quality of life, being
chemotherapy and radiotherapy inadequate to control the
oral recurrence. Obviously, reconstruction has been achieved
using the “simplest” methods, using temporalis muscle flaps,
even if a free flap reconstruction is the treatment of choice
in order to reconstruct both bone and soft tissue [12, 13].
Bone grafts were not use in order to avoid complication
in case of irradiation [14, 15]. Adjuvant radiotherapy was
not considered because of resection in free margins with
no suspect of residual disease. Nevertheless, local recurrence
was observed 5 months after surgical removal so that patient
was referred to palliative radiotherapy. In conclusion, even
if head and neck metastases from uterine leiomyosarcoma
are rare, they have to be suspected in case of rapidly
growing haemorrhagic mass. Due to the aggressive growth
pattern of the tumor, wide surgical excision in free margins
of metastatic lesions could not be sufficient, so that in
selected cases, in order to improve local control, the use
of adjuvant radiotherapy can be considered. Obviously, this
can lead to improving quality of life not influencing clinical
outcome.
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